EP3043872C0 - SOLID COMPOSITIONS BASED ON MINERALS AND MOUTH-DISSOLVING FORMULATIONS - Google Patents

SOLID COMPOSITIONS BASED ON MINERALS AND MOUTH-DISSOLVING FORMULATIONS

Info

Publication number
EP3043872C0
EP3043872C0 EP14792856.8A EP14792856A EP3043872C0 EP 3043872 C0 EP3043872 C0 EP 3043872C0 EP 14792856 A EP14792856 A EP 14792856A EP 3043872 C0 EP3043872 C0 EP 3043872C0
Authority
EP
European Patent Office
Prior art keywords
minerals
mouth
solid compositions
compositions based
dissolving formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14792856.8A
Other languages
German (de)
French (fr)
Other versions
EP3043872A1 (en
EP3043872B1 (en
Inventor
Andrea Lacorte
Germano Tarantino
Gianni Lazzarini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmanutra SpA
Original Assignee
Alesco SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco SRL filed Critical Alesco SRL
Priority to RS20240841A priority Critical patent/RS65812B1/en
Priority to HRP20241038TT priority patent/HRP20241038T1/en
Priority to SM20240310T priority patent/SMT202400310T1/en
Publication of EP3043872A1 publication Critical patent/EP3043872A1/en
Application granted granted Critical
Publication of EP3043872C0 publication Critical patent/EP3043872C0/en
Publication of EP3043872B1 publication Critical patent/EP3043872B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP14792856.8A 2013-09-09 2014-09-09 Solid compositions based on minerals and orally disintegrating formulations containing the same. Active EP3043872B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RS20240841A RS65812B1 (en) 2013-09-09 2014-09-09 Solid compositions based on minerals and orally disintegrating formulations containing the same.
HRP20241038TT HRP20241038T1 (en) 2013-09-09 2014-09-09 SOLID MIXTURES BASED ON MINERAL AND ORALLY DEGRADABLE FORMULATIONS CONTAINING THEM
SM20240310T SMT202400310T1 (en) 2013-09-09 2014-09-09 Solid compositions based on minerals and orally disintegrating formulations containing the same.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001483A ITMI20131483A1 (en) 2013-09-09 2013-09-09 COMPOSITIONS IN SOLID FORM BASED ON MINERALS AND ORO-SOLUBLE FORMULATIONS CONTAINING THE SAME.
PCT/IB2014/001780 WO2015033216A1 (en) 2013-09-09 2014-09-09 Solid compositions based on minerals and orally disintegrating formulations containing the same.

Publications (3)

Publication Number Publication Date
EP3043872A1 EP3043872A1 (en) 2016-07-20
EP3043872C0 true EP3043872C0 (en) 2024-05-01
EP3043872B1 EP3043872B1 (en) 2024-05-01

Family

ID=49354803

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14792856.8A Active EP3043872B1 (en) 2013-09-09 2014-09-09 Solid compositions based on minerals and orally disintegrating formulations containing the same.

Country Status (11)

Country Link
US (1) US11813290B2 (en)
EP (1) EP3043872B1 (en)
CA (1) CA2925188C (en)
ES (1) ES2986331T3 (en)
HR (1) HRP20241038T1 (en)
HU (1) HUE067358T2 (en)
IT (1) ITMI20131483A1 (en)
PL (1) PL3043872T3 (en)
RS (1) RS65812B1 (en)
SM (1) SMT202400310T1 (en)
WO (1) WO2015033216A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800006288A1 (en) * 2018-06-13 2019-12-13 Compositions comprising sucrosomal minerals containing mineral salts for use in the conditions of deficiency of such minerals
IT201900012804A1 (en) * 2019-07-24 2021-01-24 S I I T S R L Servizio Int Imballaggi Termosaldanti Composition comprising simethicone and sucrose esters and its use as an antifoam agent
IT202100011084A1 (en) 2021-04-30 2022-10-30 Pharmanutra S P A NUTRACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CHRONIC FATIGUE/FATIGUE POST COVID-19
IT202300001983A1 (en) 2023-02-07 2024-08-07 Pharmanutra S P A NEW ORAL COMPOSITIONS BASED ON IRON, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN CONDITIONS OF IRON DEFICIENCY
IT202300001989A1 (en) 2023-02-07 2024-08-07 Pharmanutra S P A NEW ORAL COMPOSITIONS BASED ON IRON AND SODIUM PYROPHOSPHATE, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN CONDITIONS OF IRON DEFICIENCY
IT202300001998A1 (en) 2023-02-07 2024-08-07 Pharmanutra S P A NEW ORAL COMPOSITIONS BASED ON IRON AND ACACIA GUM, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN CONDITIONS OF IRON DEFICIENCY

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818228B1 (en) * 1996-06-21 2004-11-16 Mission Pharmacal Company Dietary supplements containing ultradense calcium citrate and carbonyl iron
DE69727208T2 (en) * 1996-10-03 2004-11-25 Taiyo Kagaku Co., Ltd., Yokkaichi MINERAL COMPOSITION
US6495177B1 (en) * 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
DE10206159A1 (en) * 2002-02-14 2003-08-28 Kosmas Kg Agent containing folic acid, vitamin B6 and vitamin B12, and their use
WO2005082167A1 (en) * 2004-02-27 2005-09-09 Taiyo Kagaku Co., Ltd. Minera-containing composition and method of use thereof
US9198862B2 (en) * 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
BRPI0620425B8 (en) 2005-12-23 2021-06-22 Gupta Ajay composition for parenteral nutrition, method of preparing the same, use, and kit
ES2395862T3 (en) 2006-09-28 2013-02-15 Bayer Consumer Care Ag Mixture of iron and copper salts to mask the metallic taste
WO2012097155A1 (en) 2011-01-14 2012-07-19 Chiasma Inc. Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
ITMI20121350A1 (en) * 2012-07-31 2014-02-01 Alesco Srl IRON SOLID COMPOSITION FOR USE IN IRON DEFICIENCY CONDITIONS.
ITMI20121351A1 (en) * 2012-07-31 2014-02-01 Alesco Srl IRON-BASED LIQUID COMPOSITION FOR USE IN IRON DEFICIENCY CONDITIONS.

Also Published As

Publication number Publication date
HUE067358T2 (en) 2024-10-28
CA2925188C (en) 2023-02-14
RS65812B1 (en) 2024-08-30
PL3043872T3 (en) 2024-11-12
WO2015033216A1 (en) 2015-03-12
ITMI20131483A1 (en) 2015-03-10
SMT202400310T1 (en) 2024-09-16
CA2925188A1 (en) 2015-03-12
ES2986331T3 (en) 2024-11-11
US11813290B2 (en) 2023-11-14
EP3043872A1 (en) 2016-07-20
HRP20241038T1 (en) 2024-11-08
EP3043872B1 (en) 2024-05-01
US20160287633A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
IL272171B (en) Compositions for rna-chromatin interaction analysis and uses thereof
GB2535911B (en) Strigolactone formulations and uses thereof
IL249647A0 (en) Targeted conjugates and particles and formulations thereof
IL241225A0 (en) Plant-based compositions and uses thereof
IL243042A0 (en) Aminotriazine derivative and pharmaceutical composition comprising the same
HRP20180817T1 (en) COMPOSITIONS AND PROCEDURES FOR FARNESOID-X-RECEPTOR MODULATION
IL244850A0 (en) Stabilized efinaconazole compositions and uses thereof
PT3035940T (en) NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USES
PL3035936T3 (en) CERTAIN CHEMICAL UNITS, COMPOSITIONS AND WAYS
BR112015028459A2 (en) compositions and edibles
EP3039131C0 (en) ENZYME COMPOSITION AND USES
SG11201508122UA (en) Organic phosphor-functionalized nanoparticles and compositions comprising the same
GB201321693D0 (en) Composition and uses thereof
EP2983661C0 (en) FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES
HUE043417T2 (en) Creaming compositions and applications
DK2956410T3 (en) COMPOSITION SILICONE OR COMPOSITION PARTICLES
EP2953978C0 (en) PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF
IL276126B (en) Compositions comprising l-4-chlorokynurenine and uses thereof
EP3043872C0 (en) SOLID COMPOSITIONS BASED ON MINERALS AND MOUTH-DISSOLVING FORMULATIONS
EP3060043C0 (en) PESTICIDE COMPOSITIONS AND ASSOCIATED PROCEDURES
BR112016011430A2 (en) anticancer agents and their preparation.
EP3365010C0 (en) CYTOTOXIC IMMUNO-STIMULATIVE PARTICLES AND USES THEREOF
PT3613423T (en) HIGH ELASTICITY HYALURONAN COMPOSITIONS AND THEIR USES
EP2964610A4 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
EP2887954A4 (en) NEUROTHERAPEUTIC NANOPARTICLE COMPOSITIONS AND DEVICES THEREWITH

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HR

Ref legal event code: TUEP

Ref document number: P20241038T

Country of ref document: HR

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160324

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1226351

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180713

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61Q0019000000

Ipc: A61K0009200000

Ref document number: 602014090092

Country of ref document: DE

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/42 20060101ALI20230403BHEP

Ipc: A61K 33/26 20060101ALI20230403BHEP

Ipc: A61K 45/06 20060101ALI20230403BHEP

Ipc: A61P 3/02 20060101ALI20230403BHEP

Ipc: A23L 33/16 20160101ALI20230403BHEP

Ipc: A61K 33/18 20060101ALI20230403BHEP

Ipc: A61K 33/06 20060101ALI20230403BHEP

Ipc: A61K 9/20 20060101AFI20230403BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230526

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230908

INTC Intention to grant announced (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20231129

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ALESCO S.R.L.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LAZZARINI, GIANNI

Inventor name: TARANTINO, GERMANO

Inventor name: LACORTE, ANDREA

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014090092

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20240531

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20240610

P04 Withdrawal of opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_33763/2024

Effective date: 20240605

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: PHARMANUTRA S.P.A.

U1K Transfer of rights of the unitary patent after the registration of the unitary effect

Owner name: PHARMANUTRA S.P.A.; IT

REG Reference to a national code

Ref country code: SK

Ref legal event code: T3

Ref document number: E 44584

Country of ref document: SK

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20240401783

Country of ref document: GR

Effective date: 20241007

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20241038T

Country of ref document: HR

Payment date: 20240903

Year of fee payment: 11

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E067358

Country of ref document: HU

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 11

Effective date: 20240920

REG Reference to a national code

Ref country code: HR

Ref legal event code: T1PR

Ref document number: P20241038

Country of ref document: HR

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2986331

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20241111

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20241205 AND 20241211

P05 Withdrawal of opt-out of the competence of the unified patent court (upc) changed

Free format text: CASE NUMBER: APP_33763/2024

Effective date: 20240610

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014090092

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20250204

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20241038

Country of ref document: HR

Payment date: 20250812

Year of fee payment: 12

REG Reference to a national code

Ref country code: CH

Ref legal event code: U11

Free format text: ST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20251001

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SM

Payment date: 20250919

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MC

Payment date: 20250821

Year of fee payment: 12

Ref country code: NO

Payment date: 20250924

Year of fee payment: 12

Ref country code: GR

Payment date: 20250813

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20250811

Year of fee payment: 12

Ref country code: TR

Payment date: 20250811

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: HU

Payment date: 20250818

Year of fee payment: 12

Ref country code: GB

Payment date: 20250910

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: HR

Payment date: 20250812

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AL

Payment date: 20250813

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20250829

Year of fee payment: 12

Ref country code: RS

Payment date: 20250812

Year of fee payment: 12

Ref country code: CZ

Payment date: 20250904

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: RO

Payment date: 20250904

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SK

Payment date: 20250818

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IS

Payment date: 20250812

Year of fee payment: 12

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 12

Effective date: 20250923

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MK

Payment date: 20250813

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20251001

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CY

Payment date: 20250812

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20251007

Year of fee payment: 12